During the past decade, Institut Für Versorgungsforschung in Der Onkologie conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 6 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 4 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Institut Für Versorgungsforschung in Der Onkologie" #1 sponsor was "Hoffmann-La Roche" with 5 trials, followed by "Gilead Sciences" with 2 trials sponsored, "University of Jena" with 2 trials sponsored, "University of Leipzig" with 2 trials sponsored and "Cankado GmbH" with 2 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Institut Für Versorgungsforschung in Der Onkologie" #1 collaborator was "AstraZeneca" with 1 trials as a collaborator, "Celgene Corporation" with 1 trials as a collaborator, "Curis, Inc." with 1 trials as a collaborator, "Everest Medicines" with 1 trials as a collaborator and "German Breast Group" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Institut Für Versorgungsforschung in Der Onkologie" are "Breast Cancer" (3 trials), "Anemia" (2 trials), "Multiple Myeloma" (2 trials), "Myelodysplastic Syndromes" (2 trials) and "Chronic Myeloid Leukemia" (1 trials). Many other conditions were trialed in "Institut Für Versorgungsforschung in Der Onkologie" in a lesser frequency.

Most popular intervention types in "Institut Für Versorgungsforschung in Der Onkologie" are "Drug" (14 trials), "Other" (3 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Capecitabine" (2 trials), "Cyclophosphamide" (2 trials), "Doxorubicin" (2 trials), "Prednisone" (2 trials) and "Rituximab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Institut Für Versorgungsforschung in Der Onkologie" are 15 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Institut Für Versorgungsforschung in Der Onkologie". undefined are not yet recruiting, 3 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Institut Für Versorgungsforschung in Der Onkologie, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Institut Für Versorgungsforschung in Der Onkologie, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".